Nephrotic syndrome classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:
| bgcolor="#d9ff54"|'''Cause''' || bgcolor="#d9ff54"|'''Characteristic Features'''
| bgcolor="#d9ff54"|'''Cause''' || bgcolor="#d9ff54"|'''Characteristic Features'''
|-
|-
| bgcolor="#ececec"|'''Diabetes Mellitus''' ||
| bgcolor="#ececec"|'''[[Diabetes Mellitus]]''' ||
*[[Glucosuria]]
*[[Glucosuria]]
*[[Hyperglycemia]]
*[[Hyperglycemia]]
Line 38: Line 38:
*[[Polydipsia]]
*[[Polydipsia]]
|-
|-
| bgcolor="#ececec"|'''Systemic Lupus Erythematosus (SLE)''' ||
| bgcolor="#ececec"|'''[[Systemic Lupus Erythematosus]] (SLE)''' ||
*[[Anemia]]
*[[Anemia]]
*[[Arthralgia]]
*[[Arthralgia]]
Line 47: Line 47:
*Positive [[ANA]] and [[anti-dsDNA]] antibodies
*Positive [[ANA]] and [[anti-dsDNA]] antibodies
|-
|-
| bgcolor="#ececec"|'''Viral Hepatitis (HBV and HCV)''' ||
| bgcolor="#ececec"|'''[[Viral Hepatitis]] ([[HBV]] and [[HCV]])''' ||
*Elevated [[liver function test]]s
*Elevated [[liver function test]]s
*History of transfusions
*History of transfusions
Line 54: Line 54:
*Positive HBsAg or [[HCV]] RNA
*Positive HBsAg or [[HCV]] RNA
|-
|-
| bgcolor="#ececec"|'''NSAIDs''' ||
| bgcolor="#ececec"|'''[[NSAID]]s''' ||
*Associated with minimal change disease (MCD)
*Associated with minimal change disease (MCD)
|-
|-
|bgcolor="#ececec"|'''Amyloidosis''' ||
|bgcolor="#ececec"|'''[[Amyloidosis]]''' ||


*[[Cardiomyopathy]]
*[[Cardiomyopathy]]
Line 63: Line 63:
*[[Peripheral neuropathy]]
*[[Peripheral neuropathy]]
|-
|-
| bgcolor="#ececec"|'''Multiple Myeloma''' ||
| bgcolor="#ececec"|'''[[Multiple Myeloma]]''' ||
*Abrnomal urine protein electrophoresis (UPEP) and serum protein electrophoresis (SPEP)
*Abrnomal [[urine protein electrophoresis]] (UPEP) and [[serum protein electrophoresis]] (SPEP)
*[[Back pain]]
*[[Back pain]]
*[[Renal failure]]
*[[Renal failure]]
Line 71: Line 71:
*Positive serum beta-2-microglobulin
*Positive serum beta-2-microglobulin
|-
|-
| bgcolor="#ececec"|'''HIV''' ||
| bgcolor="#ececec"|'''[[HIV]]''' ||
*Reduced [[CD4]] cell counts
*Reduced [[CD4]] cell counts
*High-risk sexual encounters
*High-risk sexual encounters
Line 78: Line 78:
*Renal pathology similar to [[focal segmental glomerulosclerosis]] (FSGS)
*Renal pathology similar to [[focal segmental glomerulosclerosis]] (FSGS)
|-
|-
| bgcolor="#ececec"|'''Preeclampsia''' ||
| bgcolor="#ececec"|'''[[Preeclampsia]]''' ||
*[[High blood pressure]], [[edema]], and [[proteinuria]] during pregnancy
*[[High blood pressure]], [[edema]], and [[proteinuria]] during pregnancy
|}
|}

Revision as of 00:47, 5 April 2015

Nephrotic Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nephrotic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X-Ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nephrotic syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nephrotic syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nephrotic syndrome classification

CDC on Nephrotic syndrome classification

Nephrotic syndrome classification in the news

Blogs on Nephrotic syndrome classification

Directions to Hospitals Treating Nephrotic syndrome

Risk calculators and risk factors for Nephrotic syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian

Overview

Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology. Primary (idiopathic) nephrotic syndrome is defined as nephrotic syndrome due to a primary glomerular disease. Secondary nephrotic syndrome is defined as nephrotic syndrome due to a primary etiology other than glomerular disorders, such as infections, malignancies, systemic conditions, and medications.

Classification

Etiologic Classification

Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology.

 
 
 
Nephrotic
syndrome
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary
 
 
 
Secondary

Primary (Idiopathic) Nephrotic Syndrome

Primary (idiopathic) nephrotic syndrome is defined as nephrotic syndrome due to a primary glomerular disease. It is a common diagnosis in children. Etiologies of idiopathic nephrotic syndrome include:[1]:

Secondary Nephrotic Syndrome

Secondary nephrotic syndrome is defined as nephrotic syndrome due to a primary etiology other than glomerular disorders, such as infections, malignancies, systemic conditions, and medications. The most common cause of secondary nephrotic syndrome is diabetes mellitus.

Common Causes of Secondary Nephrotic Syndrome[2][1]
Cause Characteristic Features
Diabetes Mellitus
Systemic Lupus Erythematosus (SLE)
Viral Hepatitis (HBV and HCV)
  • Elevated liver function tests
  • History of transfusions
  • High-risk sexual encounters
  • IV drug use
  • Positive HBsAg or HCV RNA
NSAIDs
  • Associated with minimal change disease (MCD)
Amyloidosis
Multiple Myeloma
HIV
Preeclampsia
Adapted from Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008; 336:1185-9

References

  1. 1.0 1.1 Kodner C (2009). "Nephrotic syndrome in adults: diagnosis and management". Am Fam Physician. 80 (10): 1129–34. PMID 19904897.
  2. Hull RP, Goldsmith DJ (2008). "Nephrotic syndrome in adults". BMJ. 336 (7654): 1185–9. doi:10.1136/bmj.39576.709711.80. PMC 2394708. PMID 18497417.

Template:WH Template:WS